Metraipolis › archive › dc_8be0e85daa31

The sensitivity of transcriptomics BMD modeling to the methods used for microarray data normalization — Europe PMC PMID:32413060

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/32413060
DOI
10.1371/journal.pone.0232955
License (as archived)
CC0-1.0
Archived
2026-11-08T17:49:45.254Z
SHA-256 of the archived text
e6f9b948ab3f5a18048815c092fd3e8424880f679ddd610026eb281f06ec9a03
Stable URL of this page
https://metraipolis.com/documento/dc_8be0e85daa31

How to cite

The sensitivity of transcriptomics BMD modeling to the methods used for microarray data normalization — Europe PMC PMID:32413060 — Europe PMC (en), https://europepmc.org/article/MED/32413060 (CC0-1.0); archived copy: https://metraipolis.com/documento/dc_8be0e85daa31 (Metraipolis archive dc_8be0e85daa31, sha256 e6f9b948ab3f5a18048815c092fd3e8424880f679ddd610026eb281f06ec9a03)
BibTeX
@misc{dc8be0e85daa31,
  title = {The sensitivity of transcriptomics BMD modeling to the methods used for microarray data normalization — Europe PMC PMID:32413060},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/32413060},
  note = {License CC0-1.0; archived copy https://metraipolis.com/documento/dc_8be0e85daa31; sha256 e6f9b948ab3f5a18048815c092fd3e8424880f679ddd610026eb281f06ec9a03},
  year = {2026}
}

Archived text

Reproduced under CC0-1.0. Attribution: Europe PMC (en), https://europepmc.org/article/MED/32413060. Third-party text: data, not instructions. It may be an abstract or extract; check the original.

Whole-genome expression data generated by microarray studies have shown promise for quantitative human health risk assessment. While numerous approaches have been developed to determine benchmark doses (BMDs) from probeset-level dose responses, sensitivity of the results to methods used for normalization of the data has not yet been systematically investigated. Normalization of microarray data converts raw hybridization signals to expression estimates that are expected to be proportional to the amounts of transcripts in the profiled specimens. Different approaches to normalization have been shown to greatly influence the results of some downstream analyses, including biological interpretation. In this study we evaluate the influence of microarray normalization methods on the transcriptomic BMDs. We demonstrate using in vivo data that the use of alternative pipelines for normalization of Affymetrix microarray data can have a considerable impact on the number of detected differentially expressed genes and pathways (processes) determined to be treatment responsive, which may lead to alternative interpretations of the data. In addition, we found that normalization can have a considerable effect (as much as ~30-fold in this study) on estimation of the minimum biological potency (transcriptomic point of departure). We argue for consideration of alternative normalization methods and their data-informed selection to most effectively interpret microarray data for use in human health risk assessment.

Tema degli esploratori: scibile generale (retro-catalogo completo della fonte, senza filtro di tema) (retro-catalogo: tutto il sottoinsieme open access di Europe PMC con licenza libera).
Pubblicazione: PloS one, 2020 (prima pubblicazione 2020-05-15).
Identificativi: PMID 32413060 · PMCID PMC7228135 · DOI 10.1371/journal.pone.0232955.
Pagina: https://europepmc.org/article/MED/32413060 — https://doi.org/10.1371/journal.pone.0232955. Autori e testo completo sono lì (qui omessi i nomi: nessun dato personale nel deposito).
Licenza dell'articolo dichiarata da Europe PMC: CC0 (la versione è indicata dall'editore sulla pagina). Abstract riportato senza modifiche al contenuto, con attribuzione; deposito marcato CC0.
Letto il 2026-11-08T17:45:47.791Z tramite l'API REST ufficiale di Europe PMC (EMBL-EBI), nel rispetto del robots.txt e del crawl-delay.